In a landmark development, Neuracle Medical Technology has secured the country’s first-ever approval for an implantable brain-computer interface (BCI) system designed to restore hand motor function in patients with spinal cord injuries, in a regulatory milestone that underscores China’s accelerating push in neurotechnology.
China’s BCI start-ups, seen as potential rivals to Elon Musk’s Neuralink, are gaining momentum as regulatory support and fresh capital fuel growth.
Shares of BCI companies…
Strait of Hormuz transiting ships flash China owner signals to evade Iran blockade
...
Read moreDetails
